CRANBURY, N.J.–(BUSINESS WIRE)–Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced that on October 6, 2025, the Compensation Committee of Rocket’s Board of Directors approved the grant of inducement equity incentive awards to its newly-hired Chief Medical … [Read more…]

Launch of new healthcare plan for dual-eligible members of Medi-Cal and Medicare Enrollment begins October 15 SANTA BARBARA, Calif.–(BUSINESS WIRE)–#ACA–This week CenCal Health announced the launch of CenCal CareConnect, a new Medicare Advantage health plan designed to make healthcare simpler for people who qualify for both Medicare and Medi-Cal. Enrollment for the new plan begins … [Read more…]

ARLINGTON, Va.–(BUSINESS WIRE)–Leonardo DRS, Inc. (NASDAQ: DRS) announced today it will mark its seventh year of supporting the “Stick It to Cancer” fundraiser at the 2025 AUSA Annual Meeting & Exposition in Washington, D.C., recognizing Breast Cancer Awareness Month and supporting military members and families affected by breast cancer. As part of this ongoing initiative, … [Read more…]

ACTON, Mass.–(BUSINESS WIRE)–Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton, Massachusetts headquarters on Thursday, November 20, 2025. The Investor Day will include presentations from the management team highlighting the Company’s longer-term strategic … [Read more…]

Results presented today at ESGCT 2025 PARIS–(BUSINESS WIRE)–Genethon, a worldwide pioneer and leader in research and development of gene therapy for rare genetic diseases, and Hansa Biopharma, a Sweden-based leader in IgG cleaving enzyme technology announced today that a patient with a rare liver disease and immunity to the AAV vector has been successfully treated … [Read more…]

Analysis shows statistically significant survival benefit in individuals with infantile-onset Niemann-Pick disease type C (NPC) treated with adrabetadex compared to matched external controls Findings from an analysis of key biomarkers support the disease-modifying potential of adrabetadex in individuals with NPC THOUSAND OAKS, Calif.–(BUSINESS WIRE)–Mandos Health® by Beren Therapeutics Public Benefit Corporation (P.B.C.) announced today that … [Read more…]

AI-driven 3D imaging breakthrough recognized among the year’s most transformative innovations SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the pioneer of deep clinical AI and the global leader in image-based decision support and workflow efficiencies, today announced that its Lumina 3D™ built on the Rapid Enterprise™ Platform has been named to TIME’s List of the Best Inventions of … [Read more…]

SAN ANTONIO–(BUSINESS WIRE)–#BIAF—bioAffinity Technologies, Inc. (NASDAQ: BIAF, BIAFW) a biotechnology company focused on the need for noninvasive tests for the detection of early-stage cancer, today announced it has closed the previously announced definitive agreements for the purchase and sale of 720,000 shares of common stock at a purchase price of $2.50 per share in a … [Read more…]

RESTON, Va.–(BUSINESS WIRE)–Modus Create, a global leader in digital product engineering, today announced the appointment of Sharon Lynch as Chief Executive Officer (CEO). Lynch succeeds Pat Sheridan, co-founder of Modus Create, who will transition to the role of Chairman. Lynch brings a proven track record of helping organizations innovate, scale, and thrive in rapidly evolving … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–$hyft #AI–MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: “HYFT”), a bio-native AI company, today announced that to underscore its confidence in MindWalk’s future development and growth prospects, its Board of Directors (the “Board”) has authorized a share repurchase program under which MindWalk may repurchase up to 2.3 million common shares of the … [Read more…]